Topic's Include: Mayo Clinic’s statement on the declaration of local emergency requiring masking in indoor spaces in Rochester, how to decide what mask is best for you, and what is ‘flurona’ and why a Mayo Clinic expert says flu cases are rising.
To safeguard patient samples, staff in Mayo Clinic’s Histology Laboratory devised an inventive way to ensure that none of the paraffin-embedded blocks processed in the lab ever ends up in the trash.
This week’s research roundup features: The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
Topics Include: Mayo Clinic Q and A: Strategies for stressed kids, FDA authorizes COVID-19 boosters for 12- to 15-year-olds, and the COVID-19 tests: Different types and when to use them.
As a field service manager, Robin Mount is committed to building and leading a team of client-based specimen processors who can work independently and consistently produce accurate, high-quality work for Mayo Clinic Laboratories.
Mayo Clinic Laboratories’ comprehensive approach to targeted antibody testing played a crucial and lifesaving role in moving Sheila Lewis to recovery from autoimmune encephalitis.
Topic's Include: Hospital visitor restrictions to begin Jan. 3, 2022 in Rochester, consumer Health: children and good hand-washing habits, and Mayo Clinic Q and A: Children and video games.
This week’s research roundup features: Risk of late-onset breast cancer in genetically predisposed women.
Topic's Include: Reinfection rates of omicron and why people need to take this seriously, Mayo Clinic Q&A podcast: COVID-19 pandemic highlights health disparities, and the types of COVID-19 tests and when to use them.
This week’s research roundup features: Learning through a Pandemic: The current state of knowledge on COVID-19 and cancer.
Topic's Include: Mayo Clinic expert discusses the latest on omicron variant, one year of COVID-19 vaccines at Mayo Clinic, and predictive modeling for COVID in preparation for the holiday travel season.
Recipient of a young investigator award from the American Association of Clinical Chemistry, Dr. Maria Alice Willrich’s work has been crucial in advancing therapeutic drug monitoring to improve outcomes for patients with inflammatory bowel disease.
This week’s research roundup features: Renal Neoplasia in Polycystic Kidney Disease: An assessment of Tuberous Sclerosis complex-associated Renal Neoplasia and PKD1/TSC2 contiguous gene deletion syndrome.